Eagle Pharmaceuticals Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (47)

Latest Posts

About This Stock More About This Stock
Turn Tax Selling Stocks Into Tax Selling Bounce Stocks
Article By: Fred Fuld III
Thursday, December 7, 2023 4:42 PM EDT
Traders and investors are on the lookout for tax-selling bounce stocks that are heavily hit, hoping for a little (or big) bounce in January, once the tax-selling is over.
In this article: ORGN, EBIX, EGRX, AIRE
Read
Three Very Rare Stock Warnings From Top Analysts
Article By: TipRanks
Thursday, September 14, 2017 3:11 PM EDT
Given the hype that surrounds a potential downturn right now, it does well to keep a close eye on your stock performance. Here are some examples where top analysts diverge from the generally bullish trend.
In this article: LLY, META, EGRX
Read
Premarket Biotech Digest 2016-03-29: ACAD Nuplazid Review, APRI Tumbles, PBYI Delays NDA Filing
Article By: KKD Healthcare Analytics
Tuesday, March 29, 2016 8:31 AM EDT
Daily premarket biotech digest
In this article: ACAD, ALDR, EGRX, AXSM, BPMX, PBYI, AERI, APRI, AGLE
Read
Four Homerun Biotech Stocks Too Cheap By A Half
Article By: Bret Jensen
Sunday, February 21, 2016 12:38 PM EDT
Valuations this cheap haven’t been available in biotech since 2011, and buying any of these four stocks right now could be one of your best investing decisions of 2016.
In this article: HALO, AGEN, BDSI, EGRX, INCY, GILD, ABBV Also: MRK, ENDP, TEVA
Read
Eagle Pharmaceuticals - Chart Of The Year
Article By: Jim Van Meerten
Thursday, December 31, 2015 1:00 PM EDT
Revenue expected to grow 267.00% next year. Earnings estimated to increase 909.40% next year.
In this article: EGRX
Read

Latest Tweets for $EGRX

No tweets yet!

PARTNER HEADLINES